Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 767
Filter
5.
J Glob Health ; 13: 06006, 2023 Mar 03.
Article in English | MEDLINE | ID: covidwho-2250749

ABSTRACT

Background: During the COVID-19 pandemic, access to health care for people living with non-communicable diseases (NCDs) has been significantly disrupted. Calls have been made to adapt health systems and innovate service delivery models to improve access to care. We identified and summarized the health systems adaptions and interventions implemented to improve NCD care and their potential impact on low- and middle-income countries (LMICs). Methods: We comprehensively searched Medline/PubMed, Embase, CINAHL, Global Health, PsycINFO, Global Literature on coronavirus disease, and Web of Science for relevant literature published between January 2020 and December 2021. While we targeted articles written in English, we also included papers published in French with abstracts written in English. Results: After screening 1313 records, we included 14 papers from six countries. We identified four unique health systems adaptations/interventions for restoring, maintaining, and ensuring continuity of care for people living with NCDs: telemedicine or teleconsultation strategies, NCD medicine drop-off points, decentralization of hypertension follow-up services and provision of free medication to peripheral health centers, and diabetic retinopathy screening with a handheld smartphone-based retinal camera. We found that the adaptations/interventions enhanced continuity of NCD care during the pandemic and helped bring health care closer to patients using technology and easing access to medicines and routine visits. Telephonic aftercare services appear to have saved a significant amount of patients' time and funds. Hypertensive patients recorded better blood pressure controls over the follow-up period. Conclusions: Although the identified measures and interventions for adapting health systems resulted in potential improvements in access to NCD care and better clinical outcomes, further exploration is needed to establish the feasibility of these adaptations/interventions in different settings given the importance of context in their successful implementation. Insights from such implementation studies are critical for ongoing health systems strengthening efforts to mitigate the impact of COVID-19 and future global health security threats for people living with NCDs.


Subject(s)
COVID-19 , Delivery of Health Care , Developing Countries , Noncommunicable Diseases , Humans , COVID-19/epidemiology , Government Programs/organization & administration , Government Programs/standards , Hypertension/epidemiology , Hypertension/therapy , Noncommunicable Diseases/epidemiology , Noncommunicable Diseases/therapy , Pandemics , Delivery of Health Care/organization & administration , Delivery of Health Care/standards , Health Services Accessibility/organization & administration , Health Services Accessibility/standards , Internationality
7.
Physis (Rio J.) ; 32(4): e320404, 2022.
Article in Portuguese | WHO COVID, LILACS (Americas) | ID: covidwho-2197556

ABSTRACT

Resumo Estudo com objetivo de analisar, segundo a perspectiva de gestores e profissionais de saúde, as repercussões da pandemia por Covid-19 para os serviços de referência às hepatites virais no estado de Mato Grosso. Trata-se de pesquisa avaliativa, em abordagem descritiva de dados qualitativos, coletados por meio de entrevistas semiestruturada. A análise temática resultou em duas categorias: "Pandemia de Covid-19 e fragilidades na atenção às hepatites virais" e "Desafios da gestão na atenção às hepatites virais agravados pela pandemia". Constatou-se dificuldades de organização e implementação de estratégias para favorecer o cuidado, durante a pandemia, por ter redução no serviço administrativo na gestão estadual, ausência de diretrizes para os serviços e limitação no quantitativo de profissional, além da necessidade de remanejamento para atendimento a Covid-19. Os desafios postos pela gestão incluem a prioridade de ações estratégicas para aumentar a testagem e oportunizar acesso aos serviços de referência. Entretanto, a rotatividade de gestores e quantitativo de profissionais repercute no enfrentamento às hepatites. A organização da rede de atenção precisa avançar na governança das ações e serviços e em rearranjos organizacionais capazes de permitir respostas mais rápidas nos fluxos da atenção.


Abstract Study carried out with the objective of analyzing the repercussions of the Covid 19 pandemic on reference services for viral hepatitides in the state of Mato Grosso from the perspective of managers and health professionals. This is an evaluative research with a descriptive approach of qualitative data through semi-structured interviews. The thematic analysis resulted in two categories: "Covid-19 pandemic and weaknesses in viral hepatitis care" and "Management challenges in viral hepatitis care aggravated by the pandemic". The study found difficulties in organizing and implementing care strategies during the pandemic due to the reduction in the state administrative service, in addition to the absence of guidelines to perform the services and limitation in the number of professionals; also, due to the need for relocation to face the Covid 19 pandemic. Management challenges include prioritizing strategic actions in order to increase testing and provide access to reference services. The turnover of managers and the number of professionals have repercussions on coping with hepatitides. It is necessary to organize the care network with the objective of advancing actions and services that allow faster responses in care flows.


Subject(s)
Humans , Health Personnel , Health Management , Delivery of Health Care/organization & administration , Health Manager , COVID-19 , Hepatitis, Viral, Human/therapy , Brazil , Health Vulnerability , Health Services Accessibility
10.
Rev. chil. obstet. ginecol. (En línea) ; 87(4): 261-265, ago. 2022. tab
Article in Spanish | WHO COVID, LILACS (Americas) | ID: covidwho-2164573

ABSTRACT

Resumen Objetivo: La pandemia de SARS-CoV-2 ha obligado a una reorganización de las visitas presenciales, y por ese motivo se han minimizado hasta el punto de reconsiderar la realización de la visita del tercer trimestre. Nuestro centro suprimió dicha visita obstétrica y obtuvo datos propios para comparar los resultados perinatales logrados con dicho manejo. Método: Se realizó un estudio de cohortes retrospectivo, en marzo de 2020, con una cohorte con visita presencial única en la semana 40 de gestación (122 gestantes) frente a una cohorte con seguimiento convencional con visita presencial en la semana 36 de gestación (162 gestantes). Se evaluaron la restricción del crecimiento fetal, la edad gestacional al nacimiento, el peso neonatal y las tasas de inducciones, partos eutócicos y cesáreas urgentes en trabajo de parto. Resultados: Se encontraron diferencias leves en la tasa de nuliparidad (p < 0,04), sin hallarlas en el resto de las variables maternas. No hubo diferencias entre las dos cohortes en los resultados neonatales. Conclusiones: No hay diferencias entre los resultados materno-fetales obtenidos en gestantes con seguimiento gestacional con restricción de la visita del tercer trimestre respecto del seguimiento tradicional, excepto en el diagnóstico de las alteraciones de la estática fetal al término de la gestación.


Abstract Objective: The SARS-CoV-2 pandemic has forced a reorganization of face-to-face visits, for this reason they have been minimized to the point of reconsidering the completion of the third trimester visit. Our center eliminated the performance of this obstetric visit and obtained its own data to compare the perinatal results obtained with such management. Method: A retrospective cohort study was carried out in March 2020, with a cohort with a single face-to-face visit at 40th week of gestation (122 pregnant women), versus a cohort with conventional follow-up with face-to-face visit at 36th week of gestation (162 pregnant women). The following were evaluated fetal growth restriction, gestational age at birth, neonatal weight, rate of inductions, of eutocic deliveries, and of urgent cesarean sections in labor. Results: Slight differences were found in the nulliparity rate (p < 0.04), without finding them in the rest of the maternal variables. There were no differences between the two cohorts in neonatal outcomes. Conclusions: There were no differences between the maternal-fetal results obtained in pregnant women with gestational follow-up with restriction of the third trimester visit compared to traditional follow-up, except in the diagnosis of alterations in fetal statics at the end of pregnancy.


Subject(s)
Humans , Female , Pregnancy , Pregnancy Trimester, Third , Obstetrics and Gynecology Department, Hospital/organization & administration , Delivery of Health Care/organization & administration , COVID-19/prevention & control , Parity , Birth Weight , Pregnancy Outcome , Retrospective Studies , Gestational Age , Fetal Growth Retardation
13.
BMC Pregnancy Childbirth ; 22(1): 119, 2022 Feb 11.
Article in English | MEDLINE | ID: covidwho-1974120

ABSTRACT

BACKGROUND: The provision of care to pregnant persons and neonates must continue through pandemics. To maintain quality of care, while minimizing physical contact during the Severe Acute Respiratory Syndrome-related Coronavirus-2 (SARS-CoV2) pandemic, hospitals and international organizations issued recommendations on maternity and neonatal care delivery and restructuring of clinical and academic services. Early in the pandemic, recommendations relied on expert opinion, and offered a one-size-fits-all set of guidelines. Our aim was to examine these recommendations and provide the rationale and context to guide clinicians, administrators, educators, and researchers, on how to adapt maternity and neonatal services during the pandemic, regardless of jurisdiction. METHOD: Our initial database search used Medical subject headings and free-text search terms related to coronavirus infections, pregnancy and neonatology, and summarized relevant recommendations from international society guidelines. Subsequent targeted searches to December 30, 2020, included relevant publications in general medical and obstetric journals, and updated society recommendations. RESULTS: We identified 846 titles and abstracts, of which 105 English-language publications fulfilled eligibility criteria and were included in our study. A multidisciplinary team representing clinicians from various disciplines, academics, administrators and training program directors critically appraised the literature to collate recommendations by multiple jurisdictions, including a quaternary care Canadian hospital, to provide context and rationale for viable options. INTERPRETATION: There are different schools of thought regarding effective practices in obstetric and neonatal services. Our critical review presents the rationale to effectively modify services, based on the phase of the pandemic, the prevalence of infection in the population, and resource availability.


Subject(s)
COVID-19/prevention & control , Communicable Disease Control/organization & administration , Delivery of Health Care/organization & administration , Maternal-Child Health Services/organization & administration , Perinatal Care , Practice Guidelines as Topic , Pregnancy Complications, Infectious/prevention & control , Academic Medical Centers , COVID-19/therapy , Canada , Female , Humans , Infant , Infant, Newborn , Inpatients , Organizational Policy , Outpatients , Pregnancy , Pregnancy Complications, Infectious/therapy , SARS-CoV-2
15.
Rural Remote Health ; 21(4): 6770, 2021 11.
Article in English | MEDLINE | ID: covidwho-1716365

ABSTRACT

CONTEXT: The COVID-19 pandemic led to several changes to methadone treatment protocols at federal opioid treatment programs in the USA. ISSUE: Protocol changes were designed to reduce transmission of COVID-19 while allowing for continuity of care, but those changes also demonstrated that many policies surrounding opioid use disorder care in the USA cause unnecessary burdens to patients. In this commentary, we describe how current policies create and maintain fatal barriers to methadone treatment for people in rural communities who have opioid use disorder, and highlight how COVID-19 adaptations and more flexible methadone models in other countries can better allow for effective and accessible care. Reasons and ways to address these issues to create lasting solutions for rural communities are discussed. LESSONS LEARNED: We focus on three lessons: (1) methadone dispensing and take-home schedules during COVID-19, (2) telehealth services during COVID-19, and (3) international models in use prior to COVID-19. We then outline recommendations for each lesson to improve access to methadone treatment long term for rural communities in the USA. There is an urgent need to implement recommendations that maintain flexible approaches and address methadone treatment barriers in the rural USA. To achieve lasting health policy change and combat stigma about addiction and methadone treatment, there is a need for advocacy efforts that give voice to rural residents impacted by inequitable access to methadone treatment and rural-tailored educational initiatives that promote the evidence base for methadone. We hope opioid treatment program directors, regulatory authorities, and health policymakers consider our recommendations.


Subject(s)
COVID-19/psychology , Delivery of Health Care/organization & administration , Health Services Accessibility , Methadone/therapeutic use , Opiate Substitution Treatment/statistics & numerical data , Opioid-Related Disorders/rehabilitation , Rural Population , COVID-19/epidemiology , Humans , Opiate Substitution Treatment/methods , Opioid-Related Disorders/psychology , Pandemics , SARS-CoV-2 , United States
SELECTION OF CITATIONS
SEARCH DETAIL